A kind of preparation method of dendrimers stable ultra-small ferric oxide/gold nanoflowers
A technology of dendritic macromolecule and ferroferric oxide, which is applied in the direction of medical preparations containing active ingredients, preparations for in vivo tests, general/multifunctional contrast agents, etc. /gold nanoflowers and other problems, to achieve the effect of high practical value, small cytotoxicity, and simple preparation method
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] (1) 0.648g anhydrous ferric chloride FeCl 3 Dissolve in 40mL of diethylene glycol, stir at room temperature until completely dissolved, add 0.471g of sodium citrate, stir at 80°C for 1h until the sodium citrate is completely dissolved, then add 1.312g of anhydrous sodium acetate and continue stirring until the solution is clear, then Transfer the reaction solution to a 50mL autoclave, react at 200°C for 4h, cool to room temperature, transfer the product to a 50mL centrifuge tube and centrifuge at 8500rpm for 15min, discard the supernatant, redissolve with absolute ethanol, and centrifuge at 8500rpm for 15min. Repeat the operation 3 times, and then dry the precipitate at 60°C to obtain ultra-small ferric oxide nanoparticles Fe 3 o 4 NPs; 56mg of the nanoparticles were dispersed in 10mL of DMSO, 144mg of EDC and 70mg of NHS were dispersed in 1mL of DMSO solution, and then both were added to the ultrasmall Fe 3 o 4 NPs DMSO dispersion, stirred at room temperature for 3 ...
Embodiment 2
[0050]The present invention uses transmission electron microscopy (TEM), ultraviolet-visible spectrophotometer (UV-Vis), cell viability analysis (CCK8 test), and in vivo and in vitro MR / CT / PA multimodal imaging and photothermal therapy / radiotherapy combined treatment characterization Dendrimers-stabilized ultra-small ferric oxide / gold nanoflower G5-Fe with multimodal imaging and combined therapy prepared by the present invention 3 o 4 -AuNFs.
[0051] TEM test:
[0052] In order to characterize the morphology and size of the prepared nanoparticles, the ultra-small Fe prepared in Example 1 of the present invention were respectively taken 3 o 4 NPs, G5-Au NPs and G5-Fe 3 o 4 - 1 mg of Au NFs was dissolved in 1 mL of ultrapure water to prepare a nanoparticle suspension. Take 5 μL each ultra-small Fe 3 o 4 NPs, G5-Au NPs and G5-Fe 3 o 4 -The suspension of Au NFs was dropped on the surface of the copper grid, air-dried and used for TEM test, the results are as follows f...
Embodiment 3
[0058] Material T 1 Weighted MR Imaging Test:
[0059] To evaluate G5-Fe 3 o 4 - Imaging effect of Au NFs as MRI contrast agents, combining materials with pure ultra-small Fe 3 o 4 r of NPs 1 Relaxation rate for comparison, r 1 The relaxation rate is the longitudinal relaxation time per molar concentration of iron, which can be obtained by T at different concentrations 1 The inverse of the relaxation time was calculated by fitting. Get the ultra-small Fe prepared in Example 1 3 o 4 NPs and G5-Fe 3 o 4 -AuNFs were dissolved in ultrapure water, and the concentration of Fe in the solution was measured by ICP-OES test method, and then ultrapure water was used to prepare aqueous solutions (2mL) with Fe concentrations of 0.1, 0.2, 0.4, 0.8 and 1.6mM , to determine the T at different Fe concentrations 1 Weighted imaging (eg Figure 5 a) and T 1 relaxation time (as Figure 5 As shown in b, ultra-small Fe 3 o 4 NPs and G5-Fe 3 o 4 -T of Au NFs 1 Linear fitting graph...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


